Table 2.
Baseline characteristics between moderate and severe persistent asthma patients
| Moderate persistent asthma (n=118) | Severe persistent asthma (n=32) | P‐value | ||
|---|---|---|---|---|
| Age (mean ± SD) | 10.06 ± 2.95 | 11.19 ± 2.32 | 0.048 | |
| Sex | M : F | 86 : 32 | 24 : 8 | 0.988 |
| Family history (%) | Yes | 27 (22.9%) | 6 (18.8%) | 0.810 |
| Age of onset of illness (mean ± SD) | 67.97 ± 39.667 | 77.84 ± 39.145 | 0.212 | |
| PEFR (mean ± SD) | 72.52 ± 19.6 | 61.00 ± 16.942 | 0.003 | |
| Status of asthma (%) | Uncontrolled | 32 (27.1%) | 13 (40.6%) | 0.191 |
| Exacerbation (%) | Acute exacerbation | 38 (32.2%) | 12 (37.5%) | 0.725 |
| Prednisolone received (%) | 5 (4.2%) | 4 (12.5%) | 0.098 | |
| IgM ELISA for M. pneumoniae | 26 (22%) | 7 (21.9%) | 0.985 | |
| P1 PCR for M. pneumoniae | 8 (6.8%) | 7 (21.9%) | 0.028 |